Remove continuous
article thumbnail

Amgen's new Horizon products bolster top line despite continued Tepezza struggles

Fierce Pharma

Much of the boost can be attributed to sales of products acquired in Amgen’s $27.8 . | The buzz about Amgen’s obesity prospects overshadowed the company’s solid work on the top line as revenue came in at $7.4 billion for a 22% increase. billion buyout of Horizon Therapeutics, which was completed early in the fourth quarter of last year.

article thumbnail

Lilly cranks up outlook, banking on GLP-1 production expansions despite continuing supply squeeze

Fierce Pharma

While an ongoing production expansion push for Eli Lilly's popular tirezeptide-based medicines Mounjaro and Zepbound should help out with perpetual supply strains later this year, the expected | While Eli Lilly's supply for Mounjaro and Zepbound is scheduled to increase during the second half of the year, demand is still expected to outpace (..)

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Biogen continues to sink

World of DTC Marketing

Now two longtime board members are on the way out as well as aftershocks continue to rattle the big biotech, with all the customary handshakes and congratulatory notes you might expect.” If they decide to continue with clinical trials, a neutral, independent third party needs to review the data.

article thumbnail

Creating a winning playbook for consistent digital product success

pharmaphorum

Creating a winning playbook for consistent digital product success involves strategic planning, execution, and continuous improvement. Discover key strategies and practices to ensure your digital products achieve lasting success.

article thumbnail

Why reshoring drug production means embracing continuous manufacturing

pharmaphorum

The COVID-19 pandemic led to skyrocketing demand for some products while simultaneously constraining supplies due to logistical breakdowns and protectionist practices. The logic of outsourcing production to other countries, primarily China, suddenly looked dubious as Western countries struggled to import the drugs they needed.

article thumbnail

Product launch metrics are changing in pharma

World of DTC Marketing

The old model of looking at performance in the first six months of product launch isn’t relevant. Today, colossal budget product launches are not returning the same ROI as before. Product launches are going to need to be micro-targeted to specific audiences. What is the definition of a successful pharma product launch?

article thumbnail

Croda Pharma and BSI partner for vaccine adjuvant QS-21 production

Pharmaceutical Technology

Croda Pharma has entered a strategic collaboration deal with Botanical Solution Inc (BSI) to expedite the production of sustainable pharmaceutical-grade vaccine adjuvant QS-21. The plentiful supply of QS-21 enables the production of next-generation adjuvant systems for new vaccine development.”